{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Albemarle Corp. Stock Hits Day Low of $157.43 Amid Price Pressure
Albemarle Corp. faced a notable stock decline, dropping significantly today and over the past week. Despite a strong year-over-year performance, the company reported negative results for seven consecutive quarters, with substantial decreases in net sales and profit. Its debt management remains robust amid challenging trading conditions.
Albemarle Corp. Opens Weak with 7.18% Gap Down Amid Market Concerns
Albemarle Corp. experienced a notable decline in stock performance, contrasting with the broader market. Despite a high dividend yield, the company faces challenges with a negative return on equity. Its low debt-to-equity ratio indicates conservative leverage, while technical indicators present a mixed outlook amid market fluctuations.
Albemarle Corp. Stock Hits Day Low Amid Price Pressure at $181.95
Albemarle Corp. faced a significant stock decline today, reaching an intraday low amid a challenging trading session. Despite a strong annual return, recent financial metrics reveal a 29.31% drop in net sales and an 83.03% decrease in net profit, raising concerns about profitability and stock performance consistency.
Albemarle Corp. Opens with a 9.73% Gain, Outperforming S&P 500's 0.69% Rise
Albemarle Corp. experienced a notable opening gain, significantly outperforming the S&P 500. Despite this, the company has struggled with declining net sales and profits over recent quarters. Technical indicators suggest bullish trends, but profitability issues and a negative return on equity raise concerns about its financial health.
Albemarle Corp. Hits New 52-Week High of $205.50, Surges 71.73% Year-Over-Year
Albemarle Corp. has achieved a new 52-week high, reflecting a significant performance increase over the past year, outpacing broader market growth. With a market capitalization of nearly USD 20 billion, the company shows a low debt-to-equity ratio but is currently experiencing losses, highlighting its market volatility.
Albemarle Corp. Hits Day High with Strong 5.24% Intraday Surge
Albemarle Corp. has experienced notable stock activity, outperforming the S&P 500 over the past week. Despite a year-to-date performance significantly exceeding the broader market, the company has faced ongoing challenges, including declining net sales and profits over the last seven quarters, indicating volatility in its market position.
Albemarle Corp. Hits Day High with Strong 5.4% Intraday Surge
Albemarle Corp., a mid-cap specialty chemicals company, saw a significant rise today, outperforming the S&P 500. Despite a year of strong returns, the company has faced ongoing financial challenges, including declining sales and profits over the past seven quarters, while maintaining a solid debt management profile.
Albemarle Corp. Hits Day High with 8.5% Surge in Stock Price
Albemarle Corp. has seen a notable increase in stock performance, contrasting with the S&P 500's modest gains. Despite recent upticks, the company has faced ongoing challenges, including declining net sales and profits over the past quarters, alongside a significant long-term performance decline compared to the broader market.
Albemarle Corp. Hits Day High with Strong 7.21% Intraday Surge
Albemarle Corp., a small-cap specialty chemicals company, saw a significant intraday gain, contrasting with a decline in the S&P 500. Despite recent positive trends, the company has faced challenges over the past year, reporting consecutive quarterly losses and declining net sales and profits. Its market cap is USD 9,650 million.
Albemarle Corp. Hits Day Low of $79.30 Amid Price Pressure
Albemarle Corp., a small-cap specialty chemicals company, saw its stock decline significantly amid ongoing challenges. Over the past year, net sales dropped by 29.31%, and net profit fell by 83.03%. The company has reported negative results for seven consecutive quarters, underperforming against the S&P 500.
Albemarle Corp. Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators
Albemarle Corp., a small-cap specialty chemicals company, has recently revised its evaluation amid market fluctuations. The stock, currently priced at $81.84, has shown significant volatility over the past year, with a 52-week range from $49.43 to $113.91, reflecting ongoing recovery efforts against broader market trends.
Is Albemarle Corp. technically bullish or bearish?
As of September 10, 2025, Albemarle Corp. shows a mildly bullish technical trend, supported by positive MACD and moving averages, but has significantly underperformed the S&P 500 with a year-to-date return of -5.98% compared to 12.22%.
Is Albemarle Corp. overvalued or undervalued?
As of July 31, 2024, Albemarle Corp. is considered risky and overvalued with a P/E ratio of 7040 and an EV to EBITDA of 56.37, significantly higher than its peers, and has underperformed the S&P 500 with a year-to-date return of -5.98%.
Is Albemarle Corp. technically bullish or bearish?
As of June 6, 2025, Albemarle Corp. shows a mildly bearish trend, with conflicting signals across time frames, including a mildly bullish weekly MACD and bearish monthly indicators.
Is Albemarle Corp. overvalued or undervalued?
As of July 31, 2024, Albemarle Corp. is considered overvalued with a risky valuation grade, reflected in its high P/E ratio of 7040 and poor performance, including a year-to-date return of -32.83% compared to the S&P 500's 2.44% gain.
Who are in the management team of Albemarle Corp.?
As of March 2022, the management team of Albemarle Corp. includes Jerry Masters as Chairman, President, and CEO, with James O'Brien as Lead Independent Director and independent directors Mary Brlas, Glenda Minor, Diarmuid O'Connell, and Dean Seavers.
What does Albemarle Corp. do?
Albemarle Corporation is a global developer and manufacturer of specialty chemicals, classified as a mid-cap company with a market cap of approximately $7 billion. As of March 2025, it reported net sales of $1.077 billion and a net profit of $49 million.
How big is Albemarle Corp.?
As of Jun 18, Albemarle Corp. has a market capitalization of 7,023.18 million, with net sales of 5,093.66 million and a net profit loss of 1,102.82 million over the latest four quarters. Shareholder's funds are at 9,961.52 million, and total assets amount to 16,609.65 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
